{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:20:52Z","timestamp":1794558052553,"version":"4.9.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204662"],"award-info":[{"award-number":["82204662"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074363"],"award-info":[{"award-number":["82074363"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20372"],"award-info":[{"award-number":["U22A20372"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116541","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T07:36:35Z","timestamp":1711956995000},"page":"116541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Enhancing the therapeutic potential of isoliensinine for hypertension through PEG-PLGA nanoparticle delivery: A comprehensive in vivo and in vitro study"],"prefix":"10.1016","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2623-4342","authenticated-orcid":false,"given":"Mengying","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meizhu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aling","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10022","key":"10.1016\/j.biopha.2024.116541_bib1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis [J]","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2024.116541_bib2","doi-asserted-by":"crossref","DOI":"10.1053\/snep.2002.28639","article-title":"Pathophysiology of essential hypertension: role of the pump, the vessel, and the kidney [J]","volume":"22","author":"Cain","year":"2002","journal-title":"Semin Nephrol."},{"key":"10.1016\/j.biopha.2024.116541_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115259","article-title":"The adventitia in arterial development, remodeling, and hypertension [J]","volume":"205","author":"Majesky","year":"2022","journal-title":"Biochem Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2024.116541_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2174\/1570161121666230531153431","article-title":"Hypertension-mediated organ damage in young patients with first-diagnosed and never treated systolic hypertension [J]","volume":"21","author":"Benas","year":"2023","journal-title":"Curr. Vasc. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2024.116541_bib5","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/HYPERTENSIONAHA.115.05344","article-title":"Role of epidermal growth factor receptor and endoplasmic reticulum stress in vascular remodeling induced by angiotensin II [J]","volume":"65","author":"Takayanagi","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2024.116541_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2023.113700","article-title":"Bisbenzylisoquinoline alkaloids from Plumula Nelumbinis inhibit vascular smooth muscle cells migration and proliferation by regulating the ORAI2\/Akt pathway [J]","volume":"211","author":"Feng","year":"2023","journal-title":"Phytochemistry"},{"issue":"1","key":"10.1016\/j.biopha.2024.116541_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.5732","article-title":"A comprehensive review on chemical profiling of nelumbo nucifera: potential for drug development [J]","volume":"31","author":"Sharma","year":"2017","journal-title":"Phytother. Res"},{"issue":"1","key":"10.1016\/j.biopha.2024.116541_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12012-020-09597-z","article-title":"Isoliensinine eliminates afterdepolarizations through inhibiting late sodium current and L-type calcium current [J]","volume":"21","author":"Liu","year":"2021","journal-title":"Cardiovasc Toxicol."},{"issue":"08","key":"10.1016\/j.biopha.2024.116541_bib9","first-page":"44","article-title":"Study on the mechanism of isoliensinine in treating hypertension based on network pharmacology and experimental verification (in Chinese) [J]","volume":"54","author":"Mengying Yao","year":"2023","journal-title":"Fujian J. Tradit. Chin. Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.116541_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.apsb.2018.10.005","article-title":"Emerging transporter-targeted nanoparticulate drug delivery systems [J]","volume":"9","author":"Su","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2024.116541_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122122","article-title":"Gold nanoparticles for skin drug delivery [J]","volume":"625","author":"Chen","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2024.116541_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28052310","article-title":"Green synthesis of silver nanoparticles from allium cepa L. peel extract, their antioxidant, antipathogenic, and anticholinesterase activity [J]","volume":"28","author":"Baran","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.biopha.2024.116541_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications [J]","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.biopha.2024.116541_bib14","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/acs.accounts.2c00066","article-title":"Polymer-tethered nanoparticles: from surface engineering to directional self-assembly [J]","volume":"55","author":"Zhang","year":"2022","journal-title":"Acc. Chem. Res."},{"issue":"8","key":"10.1016\/j.biopha.2024.116541_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e19061","article-title":"Biosynthesis, characterization, and investigation of antimicrobial and cytotoxic activities of silver nanoparticles using Solanum tuberosum peel aqueous extract [J]","volume":"9","author":"Xu","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.biopha.2024.116541_bib16","first-page":"5","article-title":"A comprehensive review of advanced nano-biomaterials in regenerative medicine and drug delivery","volume":"8","author":"Khalilov","year":"2023","journal-title":"Adv. Biol. Earth Sci."},{"issue":"10","key":"10.1016\/j.biopha.2024.116541_bib17","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1080\/17425247.2020.1789585","article-title":"Polysaccharide nanoparticles for oral controlled drug delivery: the role of drug-polymer and interpolymer interactions [J]","volume":"17","author":"Bianchera","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"issue":"6","key":"10.1016\/j.biopha.2024.116541_bib18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/21691401.2017.1376675","article-title":"Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment [J]","volume":"46","author":"Afsharzadeh","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.biopha.2024.116541_bib19","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/10717544.2021.1938756","article-title":"PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application [J]","volume":"28","author":"Su","year":"2021","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2024.116541_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010204","article-title":"Exploiting PLGA-based biocompatible nanoparticles for next-generation tolerogenic vaccines against autoimmune disease [J]","volume":"20","author":"Cappellano","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2024.116541_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/17425247.2022.2075845","article-title":"Current trends in PLGA based long-acting injectable products: the industry perspective [J]","volume":"19","author":"Muddineti","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.biopha.2024.116541_bib22","doi-asserted-by":"crossref","DOI":"10.3109\/10408449309104075","article-title":"Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation [J]","volume":"23","author":"Dietrich","year":"1993","journal-title":"Crit. Rev. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116541_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability [J","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.116541_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2011.08.032","article-title":"Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications [J]","volume":"420","author":"Kawabata","year":"2011","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.biopha.2024.116541_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2017.07.001","article-title":"Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges [J]","volume":"117","author":"Cerreia Vioglio","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2024.116541_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0928-0987(02)00251-8","article-title":"Nanosizing: a formulation approach for poorly-water-soluble compounds [J]","volume":"18","author":"Merisko-Liversidge","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116541_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0192623307310946","article-title":"Drug nanoparticles: formulating poorly water-soluble compounds [J]","volume":"36","author":"Merisko-Liversidge","year":"2008","journal-title":"Toxicol. Pathol."},{"issue":"2","key":"10.1016\/j.biopha.2024.116541_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12020107","article-title":"Nanoparticle-mediated dual targeting: an approach for enhanced baicalin delivery to the liver [J]","volume":"12","author":"Ahmed","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2024.116541_bib29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12951-022-01260-9","article-title":"Multi-functional self-assembly nanoparticles originating from small molecule natural product for oral insulin delivery through modulating tight junctions [J]","volume":"20","author":"Jia","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2024.116541_bib30","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.2147\/IJN.S134148","article-title":"iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability [J]","volume":"12","author":"Gao","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"4","key":"10.1016\/j.biopha.2024.116541_bib31","article-title":"Pulmonary delivery of mucus-traversing PF127-modified silk fibroin nanoparticles loading with quercetin for lung cancer therapy [J]","volume":"18","author":"Tang","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116541_bib32","first-page":"19","article-title":"Biological activity of chalcones as carbonyl compound derivatives","volume":"8","author":"Binate","year":"2023","journal-title":"Adv. Biol. Earth Sci."},{"issue":"10","key":"10.1016\/j.biopha.2024.116541_bib33","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/1520-6017(200010)89:10<1317::AID-JPS9>3.0.CO;2-G","article-title":"Two-time window and multiangle photon correlation spectroscopy size and zeta potential analysis--highly sensitive rapid assay for dispersion stability [J","volume":"89","author":"Thode","year":"2000","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.biopha.2024.116541_bib34","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1208\/s12249-010-9519-4","article-title":"Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles [J]","volume":"11","author":"Yadav","year":"2010","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"10.1016\/j.biopha.2024.116541_bib35","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.addr.2007.05.003","article-title":"Nanosizing--oral formulation development and biopharmaceutical evaluation [J","volume":"59","author":"Kesisoglou","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.biopha.2024.116541_bib36","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1021\/bm101482r","article-title":"Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles [J]","volume":"12","author":"Yue","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biopha.2024.116541_bib37","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.2147\/IJN.S268941","article-title":"Sesamol-loaded PLGA nanosuspension for accelerating wound healing in diabetic foot ulcer in rats [J","volume":"15","author":"Gourishetti","year":"2020","journal-title":"Int J. Nanomed."},{"issue":"6","key":"10.1016\/j.biopha.2024.116541_bib38","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s13346-021-01043-z","article-title":"In vitro dissolution testing models of ocular implants for posterior segment drug delivery [J]","volume":"12","author":"Adrianto","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"3","key":"10.1016\/j.biopha.2024.116541_bib39","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1021\/nn304439f","article-title":"Nanoparticle geometry and surface orientation influence mode of cellular uptake [J]","volume":"7","author":"Herd","year":"2013","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.biopha.2024.116541_bib40","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/cr.2010.19","article-title":"Endocytosis unplugged: multiple ways to enter the cell [J]","volume":"20","author":"Kumari","year":"2010","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.biopha.2024.116541_bib41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1021\/acs.bioconjchem.8b00732","article-title":"The endosomal escape of nanoparticles: toward more efficient cellular delivery [J]","volume":"30","author":"Smith","year":"2019","journal-title":"Bioconjug Chem."},{"key":"10.1016\/j.biopha.2024.116541_bib42","doi-asserted-by":"crossref","DOI":"10.34133\/research.0148","article-title":"Advanced strategies for overcoming endosomal\/lysosomal barrier in nanodrug delivery [J]","volume":"6","author":"Qiu","year":"2023","journal-title":"Research"},{"issue":"5","key":"10.1016\/j.biopha.2024.116541_bib43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/10611860802088630","article-title":"Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate [J]","volume":"16","author":"Esmaeili","year":"2008","journal-title":"J. Drug Target"},{"issue":"10","key":"10.1016\/j.biopha.2024.116541_bib44","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1096\/fj.02-0088com","article-title":"Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery [J","volume":"16","author":"Panyam","year":"2002","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.biopha.2024.116541_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0168-3659(02)00127-X","article-title":"Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake [J]","volume":"82","author":"Sahoo","year":"2002","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2024.116541_bib46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2020.06.002","article-title":"Lipid nanoparticles for nucleic acid delivery: current perspectives [J]","volume":"154-155","author":"Samaridou","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2024.116541_bib47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0169-409X(02)00228-4","article-title":"Biodegradable nanoparticles for drug and gene delivery to cells and tissue [J]","volume":"55","author":"Panyam","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2024.116541_bib48","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1023\/A:1022219003551","article-title":"Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells [J]","volume":"20","author":"Panyam","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2024.116541_bib49","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.2147\/IJN.S410653","article-title":"Effective attenuation of arteriosclerosis following lymphatic-targeted delivery of hyaluronic acid-decorated rapamycin liposomes [J]","volume":"18","author":"Liu","year":"2023","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.biopha.2024.116541_bib50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1055\/s-2005-837821","article-title":"Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice [J]","volume":"71","author":"Xiao","year":"2005","journal-title":"Planta Med."},{"key":"10.1016\/j.biopha.2024.116541_bib51","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.2147\/IJN.S32630","article-title":"Effects of polymer molecular weight on relative oral bioavailability of curcumin [J]","volume":"7","author":"Tsai","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.biopha.2024.116541_bib52","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1042\/BST20210138","article-title":"Mechanisms of vascular smooth muscle cell investment and phenotypic diversification in vascular diseases [J]","volume":"49","author":"Worssam","year":"2021","journal-title":"Biochem Soc. Trans."},{"issue":"2","key":"10.1016\/j.biopha.2024.116541_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.tibs.2014.12.003","article-title":"Synergy in activating class I PI3Ks [J]","volume":"40","author":"Burke","year":"2015","journal-title":"Trends Biochem Sci."},{"issue":"9","key":"10.1016\/j.biopha.2024.116541_bib54","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41580-019-0129-z","article-title":"PI3K isoforms in cell signalling and vesicle trafficking [J]","volume":"20","author":"Bilanges","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.biopha.2024.116541_bib55","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.cellsig.2011.05.004","article-title":"Akt signalling in health and disease [J]","volume":"23","author":"Hers","year":"2011","journal-title":"Cell Signal"},{"issue":"2","key":"10.1016\/j.biopha.2024.116541_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2006.03.001","article-title":"Oleic acid enhances vascular smooth muscle cell proliferation via phosphatidylinositol 3-kinase\/Akt signaling pathway [J]","volume":"54","author":"Yun","year":"2006","journal-title":"Pharm. Res."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224004256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224004256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:01:24Z","timestamp":1782342084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224004256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":56,"alternative-id":["S0753332224004256"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116541","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing the therapeutic potential of isoliensinine for hypertension through PEG-PLGA nanoparticle delivery: A comprehensive in vivo and in vitro study","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116541"}}